Ironwood Pharmaceuticals

Ironwood Pharmaceuticals is a biotechnology company utilizing its development and commercial capabilities as it brings various medicines to patients. The company and its U.S. linaclotide partner Allergan plc (together with its affiliates), or Allergan, are exploring ways to enhance the clinical profile of LINZESS by studying linaclotide in additional indications, populations and formulations to assess its potential to treat various conditions. The company is developing another GI development program, IW-3718, a gastric retentive formulation of a bile acid sequestrant for the potential treatment of persistent gastroesophageal reflux disease.
  • TickerIRWD
  • ISINUS46333X1081
  • ExchangeNASDAQ Stock Market
  • SectorPharmaceuticals & Biotechnology
  • CountryUnited States

Analysts

ValuEngine Rating and Forecast Report for IRWD

ValuEngine Rating and Forecast Report for IRWD

ValuEngine Rating and Forecast Report for IRWD

ValuEngine Rating and Forecast Report for IRWD

ValuEngine Rating and Forecast Report for IRWD

ValuEngine Rating and Forecast Report for IRWD

ValuEngine Rating and Forecast Report for IRWD

ValuEngine Rating and Forecast Report for IRWD

Ashiq Mubarack ...
  • David Nierengarten
  • Jeffrey La Rosa
  • Matthew Barcus
  • Robert Driscoll

Recent Drug Launch Weekly Retail Sales Tracker - Week Ended September 6

Ashiq Mubarack ...
  • David Nierengarten
  • Jeffrey La Rosa
  • Matthew Barcus
  • Robert Driscoll

Recent Drug Launch Weekly Retail Sales Tracker - Week Ended September 6

David Nierengarten ...
  • Jeffrey La Rosa
  • Matthew Barcus

Dropping Coverage Due to Realignment of Analyst Resources

Ashiq Mubarack ...
  • David Nierengarten
  • Jeffrey La Rosa
  • Laura Chico
  • Liana Moussatos
  • Matthew Barcus
  • Robert Driscoll
  • Shveta Dighe

The Week Ahead in Life Sciences

Ashiq Mubarack ...
  • David Nierengarten
  • Jeffrey La Rosa
  • Laura Chico
  • Liana Moussatos
  • Matthew Barcus
  • Robert Driscoll
  • Shveta Dighe

The Week Ahead in Life Sciences

David Nierengarten ...
  • Jeffrey La Rosa
  • Matthew Barcus

Retail Prescription Sales Tracker - Constipation Drugs

ValuEngine Rating and Forecast Report for IRWD

ValuEngine Rating and Forecast Report for IRWD

ValuEngine Rating and Forecast Report for IRWD

ValuEngine Rating and Forecast Report for IRWD

ValuEngine Rating and Forecast Report for IRWD

ValuEngine Rating and Forecast Report for IRWD

ValuEngine Rating and Forecast Report for IRWD

ValuEngine Rating and Forecast Report for IRWD

ValuEngine Rating and Forecast Report for IRWD

ValuEngine Rating and Forecast Report for IRWD

MarketLine Department

Ironwood Pharmaceuticals, Inc. – Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

Summary Pharmaceuticals and Healthcare Key Findings Pharmaceuticals and Healthcare Pharmaceuticals and Healthcare Reasons To Buys MarketLine Key Highlights United States

Dave Nicoski ...
  • Ross LaDuke

Vermilion Booster Shots: Attractive bottom-fishing stocks

For investors looking for bottom-fishing candidates; stocks that are breaking downtrends, exhibiting ascending reaction lows, and showing stabilizing relative strength.

ResearchPool Subscriptions

Get the most out of your insights

Get in touch